The University of Chicago Header Logo

Connection

Susannah Spiess to Influenza Vaccines

Back to Details
This is a "connection" page, showing publications Susannah Spiess has written about Influenza Vaccines.
Susannah Spiess
Connection Strength
2.726
Influenza Vaccines
  1. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses. 2009 Nov; 3(6):287-95.
    View in: PubMed
    Score: 0.331
  2. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis. 2006 Oct 15; 194(8):1032-9.
    View in: PubMed
    Score: 0.266
  3. Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza. Avian Dis. 2003; 47(3 Suppl):926-30.
    View in: PubMed
    Score: 0.206
  4. Generation and characterization of an H9N2 cold-adapted reassortant as a vaccine candidate. Avian Dis. 2003; 47(3 Suppl):1127-30.
    View in: PubMed
    Score: 0.206
  5. Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. J Infect Dis. 2011 Nov 15; 204(10):1491-9.
    View in: PubMed
    Score: 0.189
  6. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology. 2011 Apr 10; 412(2):297-305.
    View in: PubMed
    Score: 0.181
  7. Influenza. Lancet. 1999 Oct 09; 354(9186):1277-82.
    View in: PubMed
    Score: 0.165
  8. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008 Dec 08; 168(22):2405-14.
    View in: PubMed
    Score: 0.155
  9. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004 May 28; 53(RR-6):1-40.
    View in: PubMed
    Score: 0.114
  10. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 2012 Oct 05; 30(45):6461-71.
    View in: PubMed
    Score: 0.100
  11. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine. 2011 Feb 17; 29(9):1836-43.
    View in: PubMed
    Score: 0.090
  12. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010 Aug 06; 59(RR-8):1-62.
    View in: PubMed
    Score: 0.087
  13. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009 Nov 12; 361(20):1945-52.
    View in: PubMed
    Score: 0.082
  14. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Jul 31; 58(RR-8):1-52.
    View in: PubMed
    Score: 0.081
  15. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis. 2008 Jul 15; 198(2):226-33.
    View in: PubMed
    Score: 0.076
  16. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008 Apr 18; 320(5874):340-6.
    View in: PubMed
    Score: 0.074
  17. Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol. 1995 Jun; 76 ( Pt 6):1521-5.
    View in: PubMed
    Score: 0.061
  18. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003 Apr 25; 52(RR-8):1-34; quiz CE1-4.
    View in: PubMed
    Score: 0.053
  19. Exposure science for viral diseases: 2009 H1N1 pandemic influenza virus. J Expo Sci Environ Epidemiol. 2011 Jan-Feb; 21(1):1-2.
    View in: PubMed
    Score: 0.045
  20. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000 Apr 14; 49(RR-3):1-38; quiz CE1-7.
    View in: PubMed
    Score: 0.043
  21. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis. 1999 Mar; 28(3):541-7.
    View in: PubMed
    Score: 0.039
  22. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol. 1999 Jul; 73(7):5903-11.
    View in: PubMed
    Score: 0.020
  23. Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. Mil Med. 1997 Feb; 162(2):82-6.
    View in: PubMed
    Score: 0.017
  24. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005 Dec 15; 353(24):2559-67.
    View in: PubMed
    Score: 0.016
  25. PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. J Virol Methods. 1995 Mar; 52(1-2):41-9.
    View in: PubMed
    Score: 0.015
  26. Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. J Infect Dis. 1994 Dec; 170(6):1432-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.